CN104072586B - The detection reagent and kit of people's kidney injury molecule-1 - Google Patents
The detection reagent and kit of people's kidney injury molecule-1 Download PDFInfo
- Publication number
- CN104072586B CN104072586B CN201310109245.3A CN201310109245A CN104072586B CN 104072586 B CN104072586 B CN 104072586B CN 201310109245 A CN201310109245 A CN 201310109245A CN 104072586 B CN104072586 B CN 104072586B
- Authority
- CN
- China
- Prior art keywords
- antibody
- polypeptide
- kim
- polyclonal antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The present invention relates to novel injury of kidney detection reagent and kits.The present inventor identifies crucial antigenic determinant respectively from the Kidney injury molecule 1 (KIM-1) of overall length, and the short-peptide mixture to contain these critical antigen determinants obtains the polyclonal antibody of the anti-KIM-1 of specificity as immunogene.Antigen fragment and its polyclonal antibody provided by the invention, preparation method is simple, and potency is high, high specificity, high sensitivity.
Description
Technical field
The invention belongs to biotechnologys and immunity field;More particularly it relates to people's kidney injury molecule-1 (KIM-
1) novel agent and kit.
Background technique
Human kidney injury molecule 1 (KIM-1) is a kind of transmembrane protein, is not expressed in normal kidney, and is damaged in kidney
Expression obviously increases in the animal model of wound.Zooscopy show KIM-1 ectodomain fracture after product can by urine in
Discharge, therefore KIM-1 level can evaluate kidney injury situation in detection urine.Existing research shows in all kidney troubles
KIM-1 level obviously increases in the expression of nephridial tissue KIM-1 and urine.Therefore, KIM-1 has been used as a kind of mark of seizure of disease
Remember that object is studied and applied by people.People KIM-1 includes 359 amino acid altogether, and wherein 1-20 are signal peptide, is removed when expression
As maturity state;21-290 are extracellular portion;291-311 are one section of cross-film sequence with 21 amino acid;Finally
48 amino acid then constitute the Intracellular domain of the albumen.
Although KIM-1 has been understood by people as the marker of medical diagnosis on disease, due to their full-length proteins
Immunogenicity itself is unsatisfactory, be immunized during obtaining antibody that there is also antibody titers poor, unstable defect.
Therefore, this field there is a need to advanced optimize the antibody for KIM-1 marker.Also, it there is a need to combine
The antibody of the relevant marker of other injury of kidney carrys out combined application in the monitoring of injury of kidney, to improve the accurate of injury of kidney diagnosis
Rate.
Summary of the invention
The purpose of the present invention is to provide a kind of novel agents and kit for monitoring injury of kidney.
In the first aspect of the present invention, a kind of isolated polypeptide is provided, it is such as SEQ ID NO:1 or SEQ ID NO:2
The polypeptide of shown amino acid sequence, the polypeptide derive from Kidney injury molecule 1 (KIM-1).
In another aspect of this invention, a kind of isolated polynucleotides are provided, it encodes the polypeptide.
In another aspect of this invention, a kind of mixtures of polypeptides is provided, by SEQ ID NO:1 and SEQ ID NO:2 institute
Show that the polypeptide of amino acid sequence mixes.
In a preferred embodiment, the ratio of the polypeptide mixing of amino acid sequence shown in SEQ ID NO:1 and SEQ ID NO:2
It is 1:5~5:1 according to weight ratio.
Preferably, the ratio that the polypeptide of amino acid sequence shown in SEQ ID NO:1 and SEQ ID NO:2 mixes is according to weight
Than for 1:3~3:1;It is more preferably 1:2~2:1 according to weight ratio.
In another aspect of this invention, the purposes of the mixtures of polypeptides is provided, the anti-kidney damage of specificity is used to prepare
Hurt the antibody of molecule 1.
In another aspect of this invention, it provides a kind of for detecting the antibody of injury of kidney, is mixed by the polypeptide
Object is immunized animal and obtains.
In a preferred embodiment, the antibody is polyclonal antibody.
In another aspect of this invention, a kind of method for preparing antibody is provided, which comprises mixed with the polypeptide
It closes object and animal is immunized, the antibody of specific anti-human kidney injury molecule-1 (KIM-1) is isolated in the animal body after being immunized.
In another aspect of this invention, it provides a kind of for detecting the kit of injury of kidney, comprising:
Solid phase carrier, and the polyclonal antibody on solid phase carrier, the polyclonal antibody are mixed by the polypeptide
Object is immunized animal and obtains;It or include: container, and above-mentioned mixtures of polypeptides in container is immunized animal and obtains
Polyclonal antibody.
In a preferred embodiment, in the kit further include: solid phase carrier, and the antibody on solid phase carrier
(such as polyclonal antibody), the antibody are the antibody of gelatinase-associated rouge fortune albumen (NGAL) of the anti-neutrophil cell of specificity;
Or include: container, and gelatinase-associated rouge fortune albumen (NGAL) of the anti-neutrophil cell of specificity in container
Antibody.
In a preferred embodiment, the solid phase carrier is coating plate, test paper and/or microballoon.
In another preferred example, the kit further include: the detection antibody of label, color developing agent, cleaning solution, terminate liquid
And/or operation instructions.
Other aspects of the invention are apparent to those skilled in the art due to this disclosure
's.
Detailed description of the invention
After Fig. 1, ELISA reaction, the absorbance in each hole on ELISA Plate, reading obtained are surveyed in A405nm.Wherein A, B row
SEQ ID NO:1 polypeptide is coated in micropore;SEQ ID NO:2 polypeptide is coated in C, D row micropore.1,2 it is classified as #YZ2861 rabbit
The serum (how anti-) of sub- 1:1000 dilution;3,4 serum for being classified as #YZ2861 rabbit 1:10,000 dilution;5,6 it is classified as #
YZ2861 rabbit 1:100,000 gradient dilution serum;7,8 serum for being classified as #YZ22862 rabbit 1:1000 dilution;3,4
It is classified as the serum of #YZ2862 rabbit 1:10,000 dilution;5,6 it is classified as #YZ2862 rabbit 1:100,000 gradient dilution blood
Clearly.A, pre-immune serum is added in the hole C;B, the serum finally obtained is added in the hole D.
Different dilutions after #YZ2861 rabbit are immunized in Fig. 2, SEQ ID NO:1 (above), SEQ ID NO:2 (following figure) respectively
Titre (potency) measurement result of the antibody of degree.
Different dilutions after #YZ2862 rabbit are immunized in Fig. 3, SEQ ID NO:1 (above), SEQ ID NO:2 (following figure) respectively
Titre (potency) measurement result of the antibody of degree.
Polyclonal antibody of the invention can specifically combine the KIM-1 of overall length as the result is shown by Fig. 4, WESTERN BLOT
Polypeptide fragment.
Specific embodiment
It is frequently found in the practice of those skilled in the art, since the antigenic determinant of albumen is easy to be embedded in protein steric
The inside of structure, therefore, it is difficult to find the high antibody of a species specificity.Problem in view of the above technology, in order to efficiently be detected
The specific antibody of KIM-1 injury of kidney marker, the present inventor pass through in-depth study, identify respectively from the KIM-1 of overall length
Crucial antigenic determinant, the short-peptide mixture to contain these critical antigen determinants obtain respectively as immunogene out
The polyclonal antibody of the anti-KIM-1 of specificity.Antigen fragment and its polyclonal antibody provided by the invention, preparation method is simple, effect
Valence is high, high specificity, high sensitivity.
In the present invention, " isolated polypeptide " refers to polypeptide substantially free of natural relative other albumen, lipid, sugar
Class or other materials, those skilled in the art can purify the polypeptide with the purified technology of protein of standard, and substantially pure is more
Peptide generates single master tape in non-reducing polyacrylamide gel.
Any polypeptide of SEQ ID NO:1-2 of the invention can be recombinant polypeptide, natural polypeptides, synthesis polypeptide,
Preferably synthetic polypeptide.Polypeptide of the present invention can be native purified product or chemically synthesized product, or use weight
Group technology is generated from protokaryon or eucaryon host (for example, bacterium, yeast, higher plant, insect and mammalian cell).
The polynucleotides of the coding polypeptide can be DNA form or rna form.DNA form includes cDNA, genome
DNA or artificial synthesized DNA.DNA can be single-stranded or double-strand.
The polynucleotides for encoding polypeptide of the invention can usually use PCR amplification method, recombination method or artificial synthesized method
It obtains.For PCR amplification method, disclosed related nucleotide sequence, especially open reading frame sequence can come according to the present invention
Design primer, and use the commercially available library cDNA or by the library cDNA prepared by conventional method well known by persons skilled in the art as mould
Plate expands and obtains related sequence.Once obtaining related sequence, so that it may obtain related sequence in large quantity with recombination method
Column.At present, it is already possible to obtain encoding the DNA sequence dna of polypeptide of the invention by chemical synthesis completely.
The present invention also provides a kind of mixtures of polypeptides, the amino acid sequence as shown in SEQ ID NO:1 and SEQ ID NO:2
The polypeptide of column mixes.
Polypeptide is prepared into mixture crosslinking and shares in carrying out animal immune as immunogene, can get the antibody of high-titer, exempts from
The significant effect of epidemic disease is immune better than single polypeptide.
The present invention also provides can specific recognition KIM-1 antibody.Here, " specificity " refers to that antibody can be identified and be tied
Together in KIM-1 albumen, but nonrecognition and the antibody for being incorporated into other non related antigen molecules.Antibody of the invention can pass through this
In field prepared by various technologies known to technical staff.
The more preferable polyclonal antibody of the present invention, in the present invention, term used " polyclonal antibody " (more anti-) refer to one group with
Antigen has the globulin of specific binding capacity, be by antigenic stimulus body, it is thin by the slurry of body after generating immunological response
Born of the same parents' synthesis and secretion.Antigen is usually to be made of multiple antigenic determinants, body is stimulated by a kind of antigenic determinant, by one
A bone-marrow-derived lymphocyte receives antibody caused by the antigen and is referred to as monoclonal antibody.Body, phase are stimulated by a variety of antigenic determinants
Just generate various monoclonal antibodies with answering, these monoclonal antibodies mixed in together are exactly polyclonal antibody.It is polyclonal
Antibody is advantageous in that their potency is high, and specificity is high, and affinity is strong, and sensitivity is good, is convenient for artificial processing and quality control,
In addition, polyclonal antibody preparation is relatively easy, it is more economical.
Polyclonal antibody can be made with various methods well known to those skilled in the art.Mixtures of polypeptides of the invention,
It can be applied to animal (such as rabbit, mouse, rat etc.;Preferably rabbit) to induce the generation of polyclonal antibody.Similar,
The cell for expressing polypeptide of the invention can also be used to immune animal to produce antibody.Polyclonal antibody can use lymph node injection
Method, subcutaneous multi-point injection method, the immunization methods such as Multiple modality injection method are made.Mixtures of polypeptides and Freund are used in embodiment
After adjuvant mixing, new zealand rabbit is immunized in dorsal sc multi-point injection;And carry out booster immunization;Final more grams for obtaining high-titer
Grand antibody.
Using mixtures of polypeptides of the invention, monoclonal antibody can also be produced.Such monoclonal antibody can use miscellaneous
Tumor technology is handed over to prepare (see Kohler et al., Nature256;495,1975;Kohler et al., Eur.J.Immunol.6:
511,1976;Kohler et al., Eur.J.Immunol.6:292,1976;Hammerling et al., In Monoclonal
Antibodies and T Cell Hybridomas, Elsevier, N.Y., 1981).A variety of adjuvants can be used for enhancing immune anti-
It answers, including but not limited to Freund's adjuvant etc..
The present invention also provides the methods that whether there is KIM-1 in test sample, are prepared by the method anti-KIM-1
Specific polyclonal antibody detected, it includes: to contact sample with the specific polyclonal antibody of anti-KIM-1;Observation
Whether antibody complex is formed, forms antibody complex and mean that there are KIM-1 in sample.More grams of the specificity of anti-KIM-1
Grand antibody, can be with well known to those skilled in the art various according to antigen-antibody In-vitro specificity for detecting KIM-1 albumen
In conjunction with the method that designs of principle reach, such as protein immunoblot experiment, co-immunoprecipitation experiment etc..
The present invention also provides a kind of detection injury of kidney kits, wherein contain antibody of the invention, preferably more grams
Grand antibody.Preferably, the detection kit includes: solid phase carrier, and the polyclonal antibody on solid phase carrier, it should
Polyclonal antibody is immunized animal by the mixtures of polypeptides and is obtained.
The solid phase carrier can be coating plate, test paper and/or microballoon.To pass through immunity test strip, colloidal gold
Etc. technologies detected.
In addition, the detection kit further include: the detection antibody of label, color developing agent, cleaning solution, terminate liquid and/or
Operation instructions.These reagents can be adjusted according to the difference of detection method.
Main advantages of the present invention are:
(1) first identified of the present invention has arrived the critical antigen determinant in KIM-1 protein sequence, with anti-containing these keys
For the short-peptide mixture of former determinant as immunogene, the antibody titer of acquisition is high, identifies that the specificity of antigen is good.
(2) polyclonal antibody is prepared using small peptide, small peptide synthetic method is simple.
(3) antigen fragment and its polyclonal antibody provided by the invention, preparation method is simple, and potency is high, high specificity, spirit
Sensitivity is high.
Present invention will be further explained below with reference to specific examples.It should be understood that these embodiments are merely to illustrate the present invention
Rather than it limits the scope of the invention.In the following examples, the experimental methods for specific conditions are not specified, usually according to conventional strip
Part such as J. Pehanorm Brooker etc. is write, Molecular Cloning:A Laboratory guide, Science Press, condition described in 2002, or according to system
Make condition proposed by manufacturer.Unless otherwise stated, otherwise percentage and number are calculated by weight.
Unless otherwise defined, it anticipates known to all professional and scientific terms as used herein and one skilled in the art
Justice is identical.In addition, any method similar to or equal to what is recorded and material all can be applied in the present invention.It is described in text
Preferred implement methods and materials be for illustrative purposes only.
In order to efficiently obtain the specific antibody of detection two kinds of injury of kidney markers of KIM-1, the present inventor is by deep
Research identifies crucial antigenic determinant, respectively from the KIM-1 of overall length with the small peptide containing these critical antigen determinants
Mixture obtains the polyclonal antibody that specificity resists anti-KIM-1 as immunogene.Antigen fragment provided by the invention and its more
Clonal antibody, preparation method is simple, and potency is high, high specificity, high sensitivity.
In the present invention, " isolated polypeptide " refers to polypeptide substantially free of natural relative other albumen, lipid, sugar
Class or other materials, those skilled in the art can purify the polypeptide with the purified technology of protein of standard, and substantially pure is more
Peptide generates single master tape in non-reducing polyacrylamide gel.
Any polypeptide of SEQ ID NO:1-2 of the invention can be recombinant polypeptide, natural polypeptides, synthesis polypeptide,
Preferably synthetic polypeptide.Polypeptide of the present invention can be native purified product or chemically synthesized product, or use weight
Group technology is generated from protokaryon or eucaryon host (for example, bacterium, yeast, higher plant, insect and mammalian cell).
The polynucleotides of the coding polypeptide can be DNA form or rna form.DNA form includes cDNA, genome
DNA or artificial synthesized DNA.DNA can be single-stranded or double-strand.
The polynucleotides for encoding polypeptide of the invention can usually use PCR amplification method, recombination method or artificial synthesized method
It obtains.For PCR amplification method, disclosed related nucleotide sequence, especially open reading frame sequence can come according to the present invention
Design primer, and use the commercially available library cDNA or by the library cDNA prepared by conventional method well known by persons skilled in the art as mould
Plate expands and obtains related sequence.Once obtaining related sequence, so that it may obtain related sequence in large quantity with recombination method
Column.At present, it is already possible to obtain encoding the DNA sequence dna of polypeptide of the invention by chemical synthesis completely.
The present invention also provides a kind of mixtures of polypeptides, the amino acid sequence as shown in SEQ ID NO:1 and SEQ ID NO:2
The polypeptide of column mixes.
Polypeptide is prepared into mixture crosslinking and shares in carrying out animal immune as immunogene, can get the antibody of high-titer, exempts from
The significant effect of epidemic disease is immune due to single polypeptide.
The present invention also provides can specific recognition KIM-1 antibody.Here, " specificity " refers to that antibody can be identified and be tied
Together in KIM-1 albumen, but nonrecognition and the antibody for being incorporated into other non related antigen molecules.Antibody of the invention can pass through this
In field prepared by various technologies known to technical staff.
The more preferable polyclonal antibody of the present invention, in the present invention, term used " polyclonal antibody " (more anti-) refer to one group with
Antigen has the globulin of specific binding capacity, be by antigenic stimulus body, it is thin by the slurry of body after generating immunological response
Born of the same parents' synthesis and secretion.Antigen is usually to be made of multiple antigenic determinants, body is stimulated by a kind of antigenic determinant, by one
A bone-marrow-derived lymphocyte receives antibody caused by the antigen and is referred to as monoclonal antibody.Body, phase are stimulated by a variety of antigenic determinants
Just generate various monoclonal antibodies with answering, these monoclonal antibodies mixed in together are exactly polyclonal antibody.It is polyclonal
Antibody is advantageous in that their potency is high, and specificity is high, and affinity is strong, and sensitivity is good, is convenient for artificial processing and quality control,
In addition, polyclonal antibody preparation is relatively easy, it is more economical.
Polyclonal antibody can be made with various methods well known to those skilled in the art.Mixtures of polypeptides of the invention,
It can be applied to animal (such as rabbit, mouse, rat etc.;Preferably rabbit) to induce the generation of polyclonal antibody.Similar,
The cell for expressing polypeptide of the invention can also be used to immune animal to produce antibody.Polyclonal antibody can use lymph node injection
Method, subcutaneous multi-point injection method, the immunization methods such as Multiple modality injection method are made.Mixtures of polypeptides and Freund are used in embodiment
After adjuvant mixing, new zealand rabbit is immunized in dorsal sc multi-point injection;And carry out booster immunization;Final acquisition high-titer
Polyclonal antibody.
Using mixtures of polypeptides of the invention, monoclonal antibody can also be produced.Such monoclonal antibody can use miscellaneous
Tumor technology is handed over to prepare (see Kohler et al., Nature256;495,1975;Kohler et al., Eur.J.Immunol.6:
511,1976;Kohler et al., Eur.J.Immunol.6:292,1976;Hammerling et al., In Monoclonal
Antibodies and T Cell Hybridomas,Elsevier,N.Y.,1981)。
A variety of adjuvants can be used for enhancing immune response, including but not limited to Freund's adjuvant etc..
It is more grams of the specificity using anti-KIM-1 the present invention also provides the method that whether there is KIM-1 in test sample
Grand antibody is detected, it includes: to contact sample with the specific polyclonal antibody of anti-KIM-1;It sees whether to form antibody
Compound forms antibody complex and means that there are KIM-1 in sample.The specific polyclonal antibody of anti-KIM-1 is resisted to be used for
KIM-1 albumen is detected, the various principles combined according to antigen-antibody In-vitro specificity well known to those skilled in the art can be used
The method of design reaches, such as protein immunoblot experiment, co-immunoprecipitation experiment etc..
The present invention also provides a kind of detection injury of kidney kits, wherein contain antibody of the invention, preferably more grams
Grand antibody.Preferably, the detection kit includes:
Container 1 or coating plate 1, and in container 1 or coating plate 1 on polyclonal antibody, the polyclonal antibody by
The mixtures of polypeptides is immunized animal and obtains.
In order to further increase the sensibility and accuracy of injury of kidney detection, it may also include in the kit and detect other
The detection reagent of injury of kidney marker.As of the invention one preferred aspect, it may also include specificity in the kit
Detect the reagent of NGAL.
For the ease of those skilled in the art's use, it may also include the use for illustrating each reagent or tool in the kit
The operation instructions of method dosage.
Main advantages of the present invention are:
(1) first identified of the present invention has arrived the antigenic determinant of KIM-1 key, to contain these critical antigen determinants
For short-peptide mixture as immunogene, the antibody titer of acquisition is high, identifies that the specificity of antigen is good.
(2) polyclonal antibody is prepared using small peptide, small peptide synthetic method is simple.
(2) antigen fragment and its polyclonal antibody provided by the invention, preparation method is simple, and potency is high, high specificity, spirit
Sensitivity is high.
Present invention will be further explained below with reference to specific examples.It should be understood that these embodiments are merely to illustrate the present invention
Rather than it limits the scope of the invention.In the following examples, the experimental methods for specific conditions are not specified, usually according to conventional strip
Part such as J. Pehanorm Brooker etc. is write, Molecular Cloning:A Laboratory guide, Science Press, condition described in 2002, or according to system
Make condition proposed by manufacturer.Unless otherwise stated, otherwise percentage and number are calculated by weight.
Unless otherwise defined, it anticipates known to all professional and scientific terms as used herein and one skilled in the art
Justice is identical.In addition, any method similar to or equal to what is recorded and material all can be applied in the present invention.It is described in text
Preferred implement methods and materials be for illustrative purposes only.
The mixture of embodiment 1, special KIM-1 amino acid fragment sequence and its product is as immunogene
Full length amino acid (source of people, the 359 amino acid) sequence (SEQ ID NO:3) of KIM-1 albumen is as follows:
MHPQVVILSLILHLADSVAGSVKVGGEAGPSVTLPCHYSGAVTSMCWNRGSCSLFTCQN
GIVWTNGTHVTYRKDTRYKLLGDLSRRDVSLTIENTAVSDSGVYCCRVEHRGWFNDMKI
TVSLEIVPPKVTTTPIVTTVPTVTTVRTSTTVPTTTTVPTTTVPTTMSIPTTTTVLTTMTVS
TTTSVPTTTSIPTTTSVPVTTTVSTFVPPMPLPRQNHEPVATSPSSPQPAETHPTTLQGA
IRREPTSSPLYSYTTDGNDTVTESSDGLWNNNQTQLFLEHSLLTANTTKGIYAGVCISVL
VLLALLGVIIAKKYFFKKEVQQLSVSFSSLQIKALQNAVEKEVQAEDNIYIENSLYATD
Since full length sequence haves the shortcomings that synthesis is difficult and immunogenicity is not strong as immunogene, the present inventor is according to above
Full length sequence, using segment as immunogene, is tested various repeatedly using the sequence fragment of the artificial synthesized various length of conventional method
The immune effect of immunogene.Finally, suitable immunogene is obtained comprising two polypeptide fragments from KIM-1, sequence (N
→ C-terminal) as follows:
CRREPTSSPLYSYTTD(SEQ ID NO:1);
CTHVTYRKDTRYKLLGDLSRRD(SEQ ID NO:2)。
Two polypeptide fragments are mixed with mass ratio 1:1, obtain mixtures of polypeptides.It is special using the mixture as production
Property Anti-TNF-α KIM-1 antibody specific immune it is former.After animal is immunized with the mixture of the two segments, can get has efficiently
The specific polyclonal antibody of valence, high immunogenicity (i.e. high antigenic).
The generation of the anti-KIM-1 antibody of embodiment 2, specific polyclonal
The mixture of the specific polypeptide prepared respectively using above-described embodiment 1 is even as immunogene and hemocyanin (KLH)
Connection is immunized new zealand white rabbit and generates immune serum.The methods and procedures of animal immune is as follows:
1) two new zealand male rabbit (#YZ2861 are immunized;#YZ2862), it acquires preimmune serum and stores in -20 DEG C.
2) first immunisation takes the immunogene being coupled with hemocyanin (KLH) and equivalent Freund's complete adjuvant to emulsify antigen
(antigen: Freund's complete adjuvant=1:1 (v/v)), back multi-point injection.The injection volume of first immunisation is 400 μ g polypeptide mixtures.
3) after 14 days, back is repeated with Freund's complete adjuvant emulsification antigen (antigen: Freund's complete adjuvant=1:1 (v/v))
Multi-point injection booster immunization.The injection volume of booster immunization is 400 μ g polypeptide mixtures.
4) it after 28 days, is mixed using same dosage polypeptide with isometric incomplete Freund's adjuvant, back multi-point injection adds
It is strong immune.
5) after 42 days, with step 4) back multi-point injection booster immunization.
6) after 70 days, with step 4) back multi-point injection booster immunization.
7) after 77 days, arteria carotis blood sampling takes serum, -70 DEG C of storages.Obtain specific antibody after, carry out ELISA and
WESTERN BLOT verifies the potency of antibody and identifies the performance of antigen.
ELISA method is as follows:
Using direct method, synthesis polypeptide is coated in 96 hole elisa Plates, Post-immunisation serum is added, compareing is immune preceding blood
Clearly.
Material:
1, envelope antigen: polypeptide antigen is coated in 96 hole elisa Plates, 0.1 hole μ g/100 μ l/;
SEQ ID NO:1 polypeptide is wherein coated in A, B row micropore of ELISA Plate;SEQ ID is coated in C, D row micropore
NO:2 polypeptide.
2, the goat antirabbit polyclonal antibody of horseradish peroxidase-labeled;
3, the dilution of antibody or enzyme conjugate: 1.0% (v/v) is prepared with 1 × PBS solution containing 0.05% (v/v) polysorbas20
BSA solution, wherein containing normal goats IgG, concentration 0.1mg/ml;
4, eluent: contain the PBS solution of 0.05% (v/v) polysorbas20;
5, ABTS substrate.
Method:
1, the polyclonal antibody of the above-mentioned preparation of the present embodiment of 100 μ l10 doubling dilutions is added in the every hole of ELISA Plate, 37
It is incubated for 30 minutes at DEG C;
2, it elutes: being added in 96 hole elisa Plates with buffer, the hole 300-360 μ l/, after 3min, washing lotion is gently thrown away,
It is placed on paper and pats dry, repeat secondary;
3, the goat anti-rabbit antibodies (1:2000) of 100 μ l horseradish peroxidase-labeleds are added in every hole, are incubated at 37 DEG C
30 minutes;
4, it elutes, eluent is added in 96 hole elisa Plates, the hole 300-360 μ l/, after 3min, eluent is gently thrown away,
It is inverted on paper and pats dry, repeat secondary;
5,100 μ l ABTS substrate solutions are added in every hole, are incubated at room temperature 10-20 minutes;
6, microplate reader is analyzed: being read under 405nm wavelength.
Fig. 1 is the reading in each hole on ELISA Plate.
ELISA is the results show that polyclonal antibody obtained can specifically identify two polypeptide fragments of KIM-1.
Fig. 2 is the antibody that different dilutions after #YZ2861 rabbit are immunized in SEQ ID NO:1 (above), SEQ ID NO:2 (following figure) respectively
Titre (potency) experimental result.Fig. 3 is that #YZ2862 is immunized in SEQ ID NO:1 (above), SEQ ID NO:2 (following figure) respectively
Titre (potency) experimental result of the antibody of different dilutions after rabbit.The results show that antibody titer is non-in Post-immunisation serum
Chang Gao.That is, the polyclonal antibody potency can reach 1:100,000.
The ability of embodiment 3, polyclonal antibody combination overall length KIM-1 polypeptide of the invention or segment
WESTERN BLOT detection is carried out, WESTERN BLOT is one of the important method with antibody detection protein.
WESTERN BLOT is operated as follows:
1. collecting protein sample
The preparation of mouse kidney after ischemic-reperfusion injury homogenate: male C57BL/6 mouse, after closing Bilateral Renal base of a fruit 30min using folder
The method of open 30min makes acute kidney injury (AKI) mouse model, and exoculation takes blood, takes tie boat anlongshore side Renal Cortex at once, after weighing
Cortex renis is shredded in super-clean bench, is homogenate agent with PBS, and homogenate, final concentration of 20g/L, homogenate operation are made in glass paste device
It is carried out in ice bath.Manufactured homogenate is centrifuged 15min, Aspirate supernatant, with 30 μm of apertures with 20000r/min low-temperature and high-speed
Disposable sterilized filter filtering, gained filtrate packing after, -70 DEG C of freezen protectives are spare.
2. electrophoresis (Electrophoresis)
(1) PAGE gel is prepared
PAGE gel is formulated as 5% concentration.
(2) sample treatment
The SDS-PAGE albumen sample-loading buffer being concentrated in right amount is added in the protein sample of collection.
(3) loading and electrophoresis
Protein sample is directly loaded in SDS-PAGE glue well, SDS-PAGE can use common electrophoresis
Instrument can be met the requirements.
3. transferring film (Transfer)
Select pvdf membrane.Using the standard wet type membrane-transferring device of Bio-Rad, transferring film electric current can be set as 300-400mA,
The transferring film time is 30-60 minutes.
4. closing (Blocking)
After transferring film, protein film is placed into preprepared Western cleaning solution immediately, is rinsed 1-2 minutes,
To wash away the transferring film liquid on film.The all steps after the transferring film, it is certain it is noted that film moisturizing, avoid the drying of film, it is no
Then easily generate higher background.
Cleaning solution is exhausted with mini desktop vacuum pump, Western confining liquid is added, is slowly shaken on shaking table, room temperature envelope
It closes 60 minutes.
5. primary antibody is incubated for
According to proper proportion dilution primary antibody (that is: of the invention is how anti-).
Confining liquid is exhausted with mini desktop vacuum pump, is added the primary antibody that has diluted immediately, room temperature or 4 DEG C are on the side shaker
Slowly shake incubation one hour.If primary antibody incubation 1 hour ineffective, overnight incubation can be slowly shaken at 4 DEG C.
Recycle primary antibody.Western cleaning solution is added, slowly shakes washing 5-10 minutes on the side shaker.Exhaust washing
After liquid, cleaning solution is added, is washed 5-10 minutes.It washs 3 times altogether.
6. secondary antibody is incubated for
According to the secondary antibody (goat antirabbit polyclonal antibody) of proper proportion dilution horseradish peroxidase (HRP) label.
Cleaning solution is exhausted with mini desktop vacuum pump, is added the secondary antibody that has diluted immediately, room temperature or 4 DEG C are on the side shaker
Slowly shake incubation one hour.
Recycle secondary antibody.Western cleaning solution is added, slowly shakes washing 5-10 minutes on the side shaker.Exhaust washing
After liquid, cleaning solution is added, is washed 5-10 minutes.It washs 3 times altogether.
7. Protein Detection
Albumen is detected using the ECL class reagent such as Western luciferase assay reagent.
As the result is shown (Fig. 4), polyclonal antibody obtained can be specifically in conjunction with overall length by WESTERN BLOT
KIM-1 polypeptide, acute kidney injury (AKI) mouse model can be distinguished most clearly with normal mice is compareed.
Embodiment 4, kit
(1) kit 1
The kit 1 includes:
Container 1, and polyclonal antibody prepared by the previous embodiment 2 loaded on container;
Container 2, and the goat antirabbit polyclonal antibody of the horseradish peroxidase-labeled loaded on container.
(2) kit 2
The kit 2 includes:
Container 1, and polyclonal antibody prepared by the previous embodiment 2 loaded on container;
Container 2, and the goat antirabbit polyclonal antibody of the horseradish peroxidase-labeled loaded on container.
The kit 2 further includes the detection reagent for detecting NGAL, as follows:
Container 3, and the anti-NGAL antibody loaded on container;
Container 4, and goat anti-human igg's polyclonal antibody of the horseradish peroxidase-labeled loaded on container.
The anti-NGAL preparation method for antibody is as follows:
According to the full length sequence of NGAL, two polypeptide fragments from NGAL are obtained, sequence (N → C-terminal) is as follows:
CREDKDPQKMYATIYELKEDKS (SEQ ID NO:4) and CYNQHAMVFFKKVSQNREY (SEQ ID NO:5).More than two
Peptide fragment is mixed with mass ratio 1:1.It is coupled, is exempted from hemocyanin (KLH) using the polypeptide fragment mixture as immunogene
Epidemic disease new zealand white rabbit and the immune serum generated.The methods and procedures of animal immune is as follows:
1) two new zealand male rabbits, simultaneously -20 DEG C of storages of acquisition preimmune serum is immunized.
2) first immunisation takes the immunogene being coupled with hemocyanin (KLH) and equivalent Freund's complete adjuvant to emulsify antigen
(antigen: Freund's complete adjuvant=1:1 (v/v)), back multi-point injection.The injection volume of first immunisation is 400 μ g polypeptide mixtures.
3) after 14 days, back is repeated with Freund's complete adjuvant emulsification antigen (antigen: Freund's complete adjuvant=1:1 (v/v))
Multi-point injection booster immunization.The injection volume of booster immunization is 400 μ g polypeptide mixtures.
4) it after 28 days, is mixed using same dosage polypeptide with isometric incomplete Freund's adjuvant, back multi-point injection adds
It is strong immune.
5) after 42 days, with step 4) back multi-point injection booster immunization.
6) after 70 days, with step 4) back multi-point injection booster immunization.
7) after 77 days, arteria carotis blood sampling takes serum, -70 DEG C of storages.
Obtain the anti-NGAL antibody of specificity.WESTERN BLOT is the results show that anti-NGAL polyclonal antibody obtained can
Specifically to combine the NGAL polypeptide of overall length.
Gelatinase-associated rouge fortune albumen (NGAL) of neutrophil cell includes 198 amino acid altogether, previous reported
It can be used as urine biomarker, for detecting the early onset thereof of renal tubular cell injury.It detects KIM-1 polypeptide and detection NGAL is more
The antibody combined application of peptide, is used for clinical diagnosis kidney injury situation, and the sensibility and accuracy of diagnosis are significantly increased.
All references mentioned in the present invention is incorporated herein by reference, independent just as each document
It is incorporated as with reference to such.In addition, it should also be understood that, after reading the above teachings of the present invention, 15 those skilled in the art
The present invention can be made various changes or modifications, such equivalent forms are equally fallen within defined by the application the appended claims
Range.
Claims (3)
1. a kind of mixtures of polypeptides, which is characterized in that its amino acid sequence as shown in SEQ ID NO:1 and SEQ ID NO:2
Polypeptide mixes.
2. mixtures of polypeptides as described in claim 1, which is characterized in that amino shown in SEQ ID NO:1 and SEQ ID NO:2
The ratio of the polypeptide mixing of acid sequence is 1:5~5:1 according to weight ratio.
3. the purposes of mixtures of polypeptides as claimed in claim 1 or 2 is used to prepare the anti-of the anti-Kidney injury molecule 1 of specificity
Body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310109245.3A CN104072586B (en) | 2013-03-29 | 2013-03-29 | The detection reagent and kit of people's kidney injury molecule-1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310109245.3A CN104072586B (en) | 2013-03-29 | 2013-03-29 | The detection reagent and kit of people's kidney injury molecule-1 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104072586A CN104072586A (en) | 2014-10-01 |
CN104072586B true CN104072586B (en) | 2019-03-01 |
Family
ID=51594225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310109245.3A Active CN104072586B (en) | 2013-03-29 | 2013-03-29 | The detection reagent and kit of people's kidney injury molecule-1 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104072586B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111153996B (en) * | 2020-01-10 | 2021-12-14 | 苏州睿瀛生物技术有限公司 | Antibody of G protein coupled receptor, preparation method thereof and G protein coupled receptor kit |
CN114778846A (en) * | 2022-03-23 | 2022-07-22 | 北京利德曼生化股份有限公司 | Kidney injury molecule (KIM-1) determination kit and detection method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101419235A (en) * | 2008-09-24 | 2009-04-29 | 吉林大学 | KIM-1 detection kit and method for making same |
CN102775486A (en) * | 2011-05-12 | 2012-11-14 | 李锐 | Novel reagent and kit for renal injury monitoring |
-
2013
- 2013-03-29 CN CN201310109245.3A patent/CN104072586B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101419235A (en) * | 2008-09-24 | 2009-04-29 | 吉林大学 | KIM-1 detection kit and method for making same |
CN102775486A (en) * | 2011-05-12 | 2012-11-14 | 李锐 | Novel reagent and kit for renal injury monitoring |
Non-Patent Citations (1)
Title |
---|
登录号:Q96D42.2;Feigelstock D.等;《GenBank》;20130306;序列第242-256位,序列第67-87位 |
Also Published As
Publication number | Publication date |
---|---|
CN104072586A (en) | 2014-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3037822A1 (en) | Mycoplasma pneumoniae immunological detection method and kit | |
JP2008515388A5 (en) | ||
CN113248590B (en) | NT-proBNP protein antigenic determinant polypeptide and application thereof | |
CN112457392B (en) | Soluble ST2 protein antigenic determinant polypeptide and application thereof | |
CN102887943A (en) | B cell epitope peptide segment of amino-terminal pro-brain natriuretic peptide and applications thereof | |
Sabater et al. | ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer | |
CN106866820B (en) | Monoclonal antibody for capturing tumor cells and resisting human keratin 18 and application thereof | |
CN102775486B (en) | The novel agent of monitoring injury of the kidney and test kit | |
CN104072586B (en) | The detection reagent and kit of people's kidney injury molecule-1 | |
CN113583132A (en) | anti-PR protein monoclonal antibody and preparation method and application thereof | |
KR20070102499A (en) | Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 | |
Westwood et al. | Epitope mapping: a practical approach | |
CN107922467A (en) | Novel protein and detection method | |
WO2024026384A1 (en) | Assays for detection and quantitation of human endotrophin | |
CN101880316A (en) | Human RBPMS polypeptide and preparation method of antibody thereof | |
CN102539778A (en) | Enzyme linked immunosorbent assay kit for detecting recombinant human tumor necrosis factor-alpha | |
CN108148127A (en) | A kind of people MAP3K7IP2 polypeptides and its preparation method for antibody | |
CN110618270A (en) | Preparation method of reagent for quantitatively determining helicobacter pylori antigen in feces | |
Marti et al. | Chicken antibodies to a recombinant fragment of the equine immunoglobulin epsilon heavy-chain recognising native horse IgE | |
JP2006115716A (en) | Cell line for producing anti-c-reactive protein monoclonal antibody, method for producing the same and monoclonal antibody produced by the cell line | |
KR100957675B1 (en) | The rapid diagnostic kits for the detection of antibodies against Paragonimus westermani and monoclonal antibodies for production of Paragonimus westermani-specific antigens | |
US5430129A (en) | Purified, native dystrophin | |
CN101928332A (en) | Preparation method of Human HNRPA0 polypeptide and antibody thereof | |
KR20100016784A (en) | A rapid diagnostic kit for clonorchis sinensis comprising the clonorchis sinensis-specific antigen and a monoclonal antibody for production of the clonorchis sinensis-specific antigen | |
JP3754611B2 (en) | Human aging marker and stress marker test method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |